NASDAQ:IRIX - IRIDEX Stock Price, Forecast & News

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

IRIDEX Co. (NASDAQ:IRIX) posted its quarterly earnings results on Thursday, November, 7th. The medical equipment provider reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.05. The medical equipment provider earned $10.66 million during the quarter, compared to the consensus estimate of $10.08 million. IRIDEX had a negative net margin of 23.42% and a negative return on equity of 37.78%. View IRIDEX's Earnings History.

IRIDEX is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for IRIDEX.

IRIDEX updated its fourth quarter 2019 After-Hours earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $11.6-11.8 million, compared to the consensus revenue estimate of $10.88 million.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRIDEX in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for IRIDEX.

Media coverage about IRIX stock has trended extremely positive on Thursday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. IRIDEX earned a news impact score of 4.4 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for IRIDEX.

IRIDEX saw a increase in short interest in December. As of December 31st, there was short interest totalling 89,500 shares, an increase of 5.7% from the December 15th total of 84,700 shares. Based on an average daily trading volume, of 46,500 shares, the short-interest ratio is currently 1.9 days. Approximately 0.8% of the company's stock are short sold. View IRIDEX's Current Options Chain.

Some companies that are related to IRIDEX include Soleno Therapeutics (SLNO), Rockwell Medical (RMTI), Fonar (FONR), BioSig Technologies (BSGM), Edap Tms (EDAP), Second Sight Medical Products (EYES), electroCore (ECOR), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), Precision Optics (PEYE), ENDRA Life Sciences (NDRA), Digirad (DRAD), Vaso (VASO), CHF Solutions (CHFS) and Nexeon Medsystems (NXNN).

Based on aggregate information from My MarketBeat watchlists, some companies that other IRIDEX investors own include SCYNEXIS (SCYX), NovaBay Pharmaceuticals (NBY), Agile Therapeutics (AGRX), CTI BioPharma (CTIC), Gilead Sciences (GILD), Trevena (TRVN), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), Capstone Turbine (CPST) and Fate Therapeutics (FATE).

Shares of IRIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRIX stock can currently be purchased for approximately $2.90.

IRIDEX has a market capitalization of $39.97 million and generates $42.60 million in revenue each year. The medical equipment provider earns $-12,810,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis. View Additional Information About IRIDEX.

The official website for IRIDEX is http://www.iridex.com/.

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The medical equipment provider can be reached via phone at 650-940-4700 or via email at [email protected]